Nevro Company
Nevro provides pain relief solutions for patients suffering from low back pain and other types of chronic pain.
Founded Date:
2006
Total Funding:
355750000
Investor Type:
N/A
Employee Number:
501-1000
Investment Stage:
N/A
Funding Status:
IPO
Number Of Exists:
N/A
Technology:
Neuromodulation
Last Funding Type:
Post-IPO Debt
Investors Number:
12
Last Funding Date:
2016
Industry:
Biotechnology, Health Care, Health Diagnostics, Pharmaceutical
Headquarters:
Menlo Park, California, United States
Estimated Revenue:
$100M to $500M